Blood Diseases Clinic

Blood Diseases Clinic (BDC) is a specialized clinical research and healthcare facility based in Peshawar, Pakistan, that focuses on the treatment and study of hematological disorders. The clinic is notably recognized for its extensive involvement in clinical trials for drug repositioning, particularly the use of thalidomide and hydroxyurea in the management of transfusion-dependent beta-thalassemia. BDC operates as a key research site in collaboration with academic institutions like the University of Peshawar and Khyber Medical University, contributing significant data to the global understanding of fetal hemoglobin induction. Its services encompass diagnostic hematology, oncology, and the management of chronic blood diseases, serving as a major referral center in the Khyber Pakhtunkhwa region.